宝洁美股招股说明书(2025-10-30版)

$258,889,000 The Procter& Gamble Company Floating Rate Notes due 2075 References to the “notes” or “floating rate notes” refer to the Floating Rate Notes due 2075. The floating rate notes will bear interestat the rate equal to Compounded SOFR (as defined herein) less 0.45% per year. Interest on the floating rate notes will be payablequarterly on February4, May4, August4 and November4 of each year, commencing on February4, 2026. The stated maturity of thenotes is November4, 2075. We have the right to redeem all or a portion of the notes beginning on November 4, 2055 and at any time thereafter at theredemption prices listed in this prospectus supplement, plus accrued interest on the notes to the date we redeem the notes. The holders of the notes may require us to repurchase all or a portion of the notes beginning on November4, 2026, on everyNovember 4 thereafter through and including November 4, 2036, and thereafter on November 4 of every subsequent third year, at therepayment prices listed in this prospectus supplement, plus accrued interest on the notes to the date we repurchase the notes. If there is a “tax event,” we have the right to shorten the maturity of the notes to the extent needed, so that the interest we pay on thenotes will be deductible for United States federal income tax purposes. On the new maturity date, we will pay 100% of the principalamount of the notes, plus accrued interest on the notes to the new maturity date. See “Risk Factors” beginning on page S-3 to read about important factors you should consider before buying the notes. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of thenotes or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representationto the contrary is a criminal offense. The initial public offering price set forth above does not include accrued interest, if any. Interest on the notes will accrue fromNovember 4, 2025 and must be paid by the purchasers if the notes are delivered after November 4, 2025. The notes will not be listed onany securities exchange. We expect to deliver the notes to investors through the book-entry delivery system of The Depository Trust Company on or aboutNovember 4, 2025. UBSInvestmentBank TABLE OF CONTENTS Prospectus Supplement About This Prospectus SupplementThe CompanyRisk FactorsSummary Consolidated Financial InformationCapitalizationDescription of the NotesUnderwritingValidity of the NotesIncorporation of Certain Information by ReferenceWhere You Can Find More Information Prospectus About This ProspectusThe CompanyCautionary Note Regarding Forward-Looking StatementsRisk FactorsUse of ProceedsDescription of Debt Securities Plan of Distribution Legal Opinions ABOUT THIS PROSPECTUS SUPPLEMENT This prospectus supplement contains the terms of this offering of notes. This prospectus supplement, or the informationincorporated by reference in this prospectus supplement, may add to, update or change the information in the accompanyingprospectus. If information in this prospectus supplement, or the information incorporated by reference in this prospectussupplement, is inconsistent with the accompanying prospectus, this prospectus supplement, or the information incorporated byreference in this prospectus supplement, will apply and will supersede that information in the accompanying prospectus. It is important for you to read and consider all information contained in this prospectus supplement and the accompanyingprospectus in making your investment decision. You should also read and consider the information in the documents we havereferred you to in “Incorporation of Certain Information by Reference” in this prospectus supplement. No person is authorized to give any information or to make any representations other than those contained or incorporatedby reference in this prospectus supplement or the accompanying prospectus and, if given or made, such information orrepresentations must not be relied upon as having been authorized. This prospectus supplement and the accompanyingprospectus do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the securitiesdescribed in this prospectus supplement or an offer to sell or the solicitation of an offer to buy such securities in anycircumstances in which such offer or solicitation is unlawful. Neither the delivery of this prospectus supplement or theaccompanying prospectus, nor any sale made hereunder or thereunder shall, under any circumstances, create any implicationthat there has been no change in our affairs since the date of this prospectus supplement or the accompanying prospectus, orthat the information contained or incorporated by reference herein or therein is correct as of any time subsequent to the date ofsuch information. The distribution of this prospectus supplement and the accompanying prospectus and the offering